Basic info
Industry
biotechnology research
Sectors
Cardiovascular Disease
Biotechnology
Therapeutics
Peripheral Artery Disease
Cell Therapy
Clinical Trials
Critical Limb Ischemia
Date founded
2006
Funding rounds raised
Total raised
$250K
from 1 investors over 1 rounds
H
Hemostemix raised $250K on January 19, 2023
Investors: Fondation de l'Hôpital Royal Victoria / Royal Victoria Hospital Foundation